High PTGS2 expression in post neoadjuvant chemotherapy treated oesophageal adenocarcinoma is associated with improved survival: a population ‐based cohort study
ConclusionsHigh PTGS2 expression in oesophageal adenocarcinoma tissue was associated with improved overall and cancer ‐specific survival, contrasting previous evidence. As this is the first study of its kind to include patients who had undergone neoadjuvant chemotherapy further studies are needed to clarify these associations.This article is protected by copyright. All rights reserved.
Source: Histopathology - Category: Pathology Authors: Andrew D Spence,
James Trainor, Úna McMenamin,
Richard C Turkington,
Stephen McQuaid,
Victoria Bingham,
Jacqueline James,
Manuel Salto‐Tellez,
Damian T McManus,
Brian T Johnston,
Chris R Cardwell,
Helen G Coleman Tags: Original Article Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Chemotherapy | Esophagus Cancer | Ireland Health | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Pathology | Study